We summarized the history of the sphingolipid pathway focusing on the sphingomyelin cycle.
We described the main biologic pathophysiologies involving sphingomyelin synthases and specific sphingomyelinases.
We numbered, described and named examples of their use of the most used inhibitors for sphingomyelin synthases and sphingomyelinases.